We are live on ! Find out more
ORC

O'Rourke & Company Portfolio holdings

AUM $253M
1-Year Est. Return 16.72%
This Fund
S&P 500
This Quarter Est. Return
-5.78%
1 Year Est. Return
+16.72%
3 Year Est. Return
+62.38%
5 Year Est. Return
10 Year Est. Return
AUM
$115M
AUM Growth
-$3.3M
Cap. Flow
+$4.5M
Cap. Flow %
3.93%
Top 10 Hldgs %
41.21%
Holding
121
New
7
Increased
69
Reduced
32
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 15.13%
2 Financials 14.39%
3 Healthcare 5.68%
4 Communication Services 3.58%
5 Consumer Discretionary 3.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
26
IBM
IBM
$213B
$1.18M 1.03%
9,947
+572
+6% +$75.1K
VFH icon
27
Vanguard Financials ETF
VFH
$13.6B
$1.16M 1.01%
15,589
-155
-1% -$12.6K
BRK.B icon
28
Berkshire Hathaway Class B
BRK.B
$1.11T
$1.1M 0.96%
4,126
+200
+5% +$56.9K
PHO icon
29
Invesco Water Resources ETF
PHO
$2.03B
$1.09M 0.95%
23,888
+2,933
+14% +$146K
BLK icon
30
Blackrock
BLK
$175B
$1.04M 0.91%
1,896
-155
-8% -$101K
KO icon
31
Coca-Cola
KO
$374B
$1.01M 0.88%
17,949
+204
+1% +$12.7K
WELL icon
32
Welltower
WELL
$168B
$980K 0.86%
15,233
+1,296
+9% +$101K
WAT icon
33
Waters Corp
WAT
$36.8B
$965K 0.84%
3,582
PFE icon
34
Pfizer
PFE
$143B
$840K 0.73%
19,204
+558
+3% +$27.1K
VZ icon
35
Verizon
VZ
$197B
$818K 0.71%
21,549
-512
-2% -$22.8K
IBB icon
36
iShares Biotechnology ETF
IBB
$9.18B
$791K 0.69%
6,759
-197
-3% -$24.5K
EBC icon
37
Eastern Bankshares
EBC
$5.29B
$777K 0.68%
39,584
-1,100
-3% -$22K
GS icon
38
Goldman Sachs
GS
$303B
$777K 0.68%
2,652
+335
+14% +$109K
GSK icon
39
GSK
GSK
$103B
$773K 0.67%
26,252
+3,242
+14% +$123K
VB icon
40
Vanguard Morningstar Small-Cap ETF
VB
$80.7B
$758K 0.66%
4,437
-279
-6% -$52.7K
PG icon
41
Procter & Gamble
PG
$338B
$741K 0.65%
5,866
+260
+5% +$36.9K
DVY icon
42
iShares Select Dividend ETF
DVY
$23.6B
$727K 0.63%
6,779
+5
+0.1% +$599
SPY icon
43
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$722K 0.63%
2,021
-177
-8% -$70.3K
XLV icon
44
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$674K 0.59%
5,565
+265
+5% +$34.1K
VYM icon
45
Vanguard High Dividend Yield ETF
VYM
$81.4B
$640K 0.56%
6,740
+475
+8% +$49.4K
FTCS icon
46
First Trust Capital Strength ETF
FTCS
$7.86B
$638K 0.56%
9,604
+3
+0% +$216
VO icon
47
Vanguard Morningstar Mid-Cap ETF
VO
$108B
$628K 0.55%
13,368
-796
-6% -$41.6K
BMY icon
48
Bristol-Myers Squibb
BMY
$134B
$625K 0.55%
8,791
-1,550
-15% -$112K
VBR icon
49
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.6B
$601K 0.52%
4,193
+636
+18% +$101K
VIG icon
50
Vanguard Dividend Appreciation ETF
VIG
$112B
$599K 0.52%
4,431
+5
+0.1% +$744

Similar funds

O'Rourke & Company's Q3 2022 Portfolio in Review

As of Q3 2022, O'Rourke & Company held 121 positions worth $115M, down 2.8% from $118M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

O'Rourke & Company deployed $4.5M of net new capital in Q3 2022, opening 7 new positions and adding to 69 existing holdings. Its largest new stake was Vanguard International Dividend Appreciation ETF: 7,002 shares worth $434K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Total International Stock ETF, an estimated $399K trimmed.

  • O'Rourke & Company's largest Q3 2022 buy was Vanguard International Dividend Appreciation ETF: 7,002 shares worth $434K.
  • O'Rourke & Company added most to Vanguard Tax-Exempt Bond Index Fund in Q3 2022, an estimated $1.11M increase.
  • O'Rourke & Company's biggest Q3 2022 reduction was Vanguard Total International Stock ETF, cutting an estimated $399K.
  • O'Rourke & Company fully exited iShares Core S&P Mid-Cap ETF in Q3 2022, selling an estimated $213K.
  • O'Rourke & Company's ten largest holdings make up 41% of its $115M portfolio in Q3 2022.
  • O'Rourke & Company opened 7 new positions and closed 4 in Q3 2022.
  • O'Rourke & Company's portfolio value fell 2.8% quarter-over-quarter to $115M.

Based on O'Rourke & Company's 13F filing for Q3 2022, filed 14 Nov 2022.